Research Article

Optimization of kanamycin dose for in vitro Camelina sativa transformation

Volume: 7 Number: 1 June 30, 2024
EN

Optimization of kanamycin dose for in vitro Camelina sativa transformation

Abstract

Camelina sativa is an underutilized oilseed crop that can be grown under different climate conditions. As its requirements for growth are relatively low with a short life cycle, it can be utilized in marginal lands for crop rotations. Camelina shows great promise as a source of food, feed, chemicals, and biofuel. Enabling the genetic transformation of C. sativa would facilitate the fast incorporation of new characteristics into this growing crop. Moreover, genetic and metabolic engineering can be applied to decrease unwanted secondary metabolites as well as boost the beneficial products. Kanamycin is one of the most used antibiotics in plant transformation. Here, the effects of kanamycin on the seeds of Camelina were analyzed by observing different parameters such as germination, seedlings, shoot, and root growth as well as its fresh and dry weight. Prevalent effects of kanamycin were shortening of root and shoot length, thinning of shoots, and discoloration. Also, true leaves could not grow in the presence of the antibiotic. Based on these results using 100mg/L kanamycin as an additive to the growth media in tissue culture would allow the selection of transformant plants and allow them to grow as transgenic plants for desired purposes.

Keywords

References

  1. Aasim M, Sahin-Demirbag N, Khawar KM, Kendir H, Özcan S. 2011. Direct Axillary hoot Regeneration From The Mature Seed Explant Of The Hairy Vetch (Vicia villosa Roth). Arch Biol Sci. 63(3):757-762
  2. Ahmed HAA, Onarici S, Bakhsh A, Akdoğan G, Karakoç OC, Özcan SF, Aydın G, Aasim M, Ünlü L, Sancak C, Naimov S, Özcan S. 2017. Targeted expression of insecticidal hybrid SN19 gene in potato leads to enhanced resistance against Colorado potato beetle (Leptinotarsa decemlineata Say) and tomato leafminer (Tuta absoluta Meyrick). Plant Biotechnol Rep. 11:315–329
  3. Anayol E, Bakhsh A, Karakoç OC, Onarici S, Kom D, Aasim M, Ozcan FS, Barpete S, Khakbazi SD, Önol B, Sancak C, Khawar KM, Ünlü L, Özcan S. 2016. Towards better insect management strategy: restriction of insecticidal gene expression to biting sites in transgenic cotton. Plant Biotechnol Rep. 10(2): 83-94
  4. Bakhsh A, Anayol E, Özcan SF, Hussain T, Aasim M, Khawar KM, Özcan S. 2015. An insight into cotton genetic engineering (Gossypium hirsutum L.): current endeavors and prospects. Acta Physiol Plant 37:1-17
  5. Bansal S, Durrett TP. 2016. Camelina sativa: An ideal platform for the metabolic engineering and field production of industrial lipids. Biochimie. 120:9-16
  6. Berti M, Gesch R, Eynck C, Anderson J, and Cermak S. 2016. Camelina uses, genetics, genomics, production, and management. Ind Crops Prod. 94: 690-710
  7. Ghamkhar K. Croser J, Aryamanesh N, Campbell M, Kon’kova N, Francis C. 2010. Camelina (Camelina sativa (L.) Crantz) as an alternative oilseed: molecular and ecogeographic analyses. Genome. 53(7):558-567
  8. Ghidoli M, Ponzoni, E, Araniti F, Miglio D, Pilu R. 2023. Genetic Improvement of Camelina sativa (L.) Crantz: Opportunities and Challenges. Plants. 12(3):570

Details

Primary Language

English

Subjects

Plant Biotechnology

Journal Section

Research Article

Authors

Publication Date

June 30, 2024

Submission Date

December 23, 2023

Acceptance Date

April 16, 2024

Published in Issue

Year 2024 Volume: 7 Number: 1

APA
Mustafa, Z. (2024). Optimization of kanamycin dose for in vitro Camelina sativa transformation. Eurasian Journal of Biological and Chemical Sciences, 7(1), 41-45. https://doi.org/10.46239/ejbcs.1408973
AMA
1.Mustafa Z. Optimization of kanamycin dose for in vitro Camelina sativa transformation. Eurasian J. Bio. Chem. Sci. 2024;7(1):41-45. doi:10.46239/ejbcs.1408973
Chicago
Mustafa, Zemran. 2024. “Optimization of Kanamycin Dose for in Vitro Camelina Sativa Transformation”. Eurasian Journal of Biological and Chemical Sciences 7 (1): 41-45. https://doi.org/10.46239/ejbcs.1408973.
EndNote
Mustafa Z (June 1, 2024) Optimization of kanamycin dose for in vitro Camelina sativa transformation. Eurasian Journal of Biological and Chemical Sciences 7 1 41–45.
IEEE
[1]Z. Mustafa, “Optimization of kanamycin dose for in vitro Camelina sativa transformation”, Eurasian J. Bio. Chem. Sci., vol. 7, no. 1, pp. 41–45, June 2024, doi: 10.46239/ejbcs.1408973.
ISNAD
Mustafa, Zemran. “Optimization of Kanamycin Dose for in Vitro Camelina Sativa Transformation”. Eurasian Journal of Biological and Chemical Sciences 7/1 (June 1, 2024): 41-45. https://doi.org/10.46239/ejbcs.1408973.
JAMA
1.Mustafa Z. Optimization of kanamycin dose for in vitro Camelina sativa transformation. Eurasian J. Bio. Chem. Sci. 2024;7:41–45.
MLA
Mustafa, Zemran. “Optimization of Kanamycin Dose for in Vitro Camelina Sativa Transformation”. Eurasian Journal of Biological and Chemical Sciences, vol. 7, no. 1, June 2024, pp. 41-45, doi:10.46239/ejbcs.1408973.
Vancouver
1.Zemran Mustafa. Optimization of kanamycin dose for in vitro Camelina sativa transformation. Eurasian J. Bio. Chem. Sci. 2024 Jun. 1;7(1):41-5. doi:10.46239/ejbcs.1408973